San Diego, CA - Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) announced today it has formed a new subsidiary, Regen BioPharma, Inc. Regen BioPharma has developed a vertically-integrated structure for acquiring patents, performing accelerating preclinical and clinical development, and licensing or selling technology developed to large pharma companies in the area of stem cells.
To date,...
Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary; Regen BioPharma Inc., Secures $20,000,000 In Institutional Funding - Southridge Partners to provide $20 million in funding for the rapid commercialization of stem cell therapy
April 30, 2012 at 08:59 AM EDT
